{'fraction_non_alphanumeric': 0.0300187617260788, 'fraction_numerical': 0.0075046904315197, 'mean_word_length': 5.512195121951219, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Potential use of serum insulin‐like growth factor 1 and E‐cadherin as biomarkers of colorectal cancer

Despite many efforts, reliable biomarkers for the prediction and diagnosis of colorectal cancer (CRC) are still missing. Insulin‐like growth factor 1 (IGF‐1) and E‐cadherin are recognized as potential biomarkers, but their diagnostic capacity is largely unexplored in CRC. The aim of this work is to investigate IGF‐1 and E‐cadherin levels with respect to various characteristics of CRC and to estimate their diagnostic potential.